MedicarePartD.guide

A non-government resource built from CMS public data

Mounjaro on HealthSpring Assurance Rx (S5617-217)

tirzepatide injection

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 2 per 28 days.

$233.03
Patient pays / month, after deductible
$712.73
Patient pays / month, before the $615.00 deductible
$699.09
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

MOUNJARO 10 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,059.22 for a month. Other covered strengths are listed below.

Prior authRequired on all 6 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 6 covered strengths and forms
FormTierPatient pays / monthLimits
MOUNJARO 15 mg/.5mL Injection, Solution3$233.45PA · 2 per 28 days
MOUNJARO 12.5 mg/.5mL Injection, Solution3$233.59PA · 2 per 28 days
MOUNJARO 10 mg/.5mL Injection, Solution3$233.03PA · 2 per 28 days
MOUNJARO 7.5 mg/.5mL Injection, Solution3$233.11PA · 2 per 28 days
MOUNJARO 5 mg/.5mL Injection, Solution3$233.57PA · 2 per 28 days
MOUNJARO 2.5 mg/.5mL Injection, Solution3$234.24PA · 2 per 28 days

Other GLP-1s on this plan

Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5617-217